Natixis Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.7M Buy
2025
Q1
$851K Sell
2024
Q4
$2.14M Sell
2024
Q3
$2.92M Buy
2024
Q2
$554K Sell
2024
Q1
$639K Sell
2023
Q4
$731K Buy
2023
Q3
$492K Sell
2023
Q2
$727K Buy
2023
Q1
$451K Buy
2022
Q4
$475K Buy